USFDA in 2013 banned imports from Chikalthana and Waluj plants for violations of current good manufacturing practices. Upon completion of an inspection, USFDA provides establishments an EIR. The company also said receipt of an EIR does not change the existing status of the plants, which are under USFDA import alerts. Photo: BloombergHyderabad: Drug maker Wockhardt Ltd on Thursday said it had received an establishment inspection report (EIR) with observations from the US Food and Drug Administration (USFDA) on three of its facilities in Maharashtra. “Receipt of EIR does not materially change the status of import alert for the concerned manufacturing units for the US market,” Wockhardt said.

Source: Mint July 21, 2016 15:13 UTC